scholarly article | Q13442814 |
P356 | DOI | 10.1053/JHEP.2001.21048 |
P698 | PubMed publication ID | 11124835 |
P2093 | author name string | Takahashi C | |
Mori A | |||
Noda M | |||
Isobe N | |||
Murata T | |||
Arii S | |||
Imamura M | |||
Furumoto K | |||
Nakao T | |||
Furuyama H | |||
Gorrin Rivas MJ | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
P304 | page(s) | 189-195 | |
P577 | publication date | 2001-01-01 | |
P1433 | published in | Hepatology | Q15724398 |
P1476 | title | RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing--cysteine-rich protein with Kazal motifs | |
P478 | volume | 33 |
Q38739352 | Anacardic acid inhibits gelatinases through the regulation of Spry2, MMP-14, EMMPRIN and RECK. |
Q35440600 | Association between polymorphisms in tumor suppressor genes and oncogenes and risk of hepatocellular carcinoma: a case-control study in an HCC epidemic area within the Han Chinese population |
Q28288148 | Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade |
Q46103336 | Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness |
Q34574350 | Developmental biology: vasculogenesis is a wreck without RECK. |
Q43049939 | Differential expression of degradome components in cutaneous squamous cell carcinomas |
Q39631853 | Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases. |
Q34201053 | Effect of RECK gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features |
Q39956136 | Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells |
Q83389319 | Estrogen suppresses expression of the matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs (RECK) within the mouse uterus |
Q37719954 | Expression of RECK and MMP-2 in salivary adenoid cystic carcinoma: Correlation with tumor progression and patient prognosis |
Q82039791 | Expression of matrix metalloproteinase regulator, RECK, and its clinical significance in osteosarcoma |
Q61818499 | GAS5 Regulates RECK Expression and Inhibits Invasion Potential of HCC Cells by Sponging miR-135b |
Q34479560 | HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion |
Q34206316 | HPV16 oncoproteins induce MMPs/RECK-TIMP-2 imbalance in primary keratinocytes: possible implications in cervical carcinogenesis. |
Q35463638 | High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity |
Q40196754 | Higher expression and activity of metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence. |
Q53618959 | Immunohistochemical detection of MT1-MMP, RECK, and EMMPRIN in ameloblastic tumors. |
Q36215892 | Keratinization-associated miR-7 and miR-21 regulate tumor suppressor reversion-inducing cysteine-rich protein with kazal motifs (RECK) in oral cancer. |
Q24540058 | Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma |
Q42520559 | Localization of the membrane-anchored MMP-regulator RECK at the neuromuscular junctions |
Q44201369 | Low expression of RECK indicates a shorter survival for patients with invasive breast cancer |
Q73437447 | Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma |
Q34696685 | MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis |
Q39240146 | MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression |
Q78357688 | Molecular pathogenesis of human hepatocellular carcinoma |
Q36142628 | RECK is not an independent prognostic marker for breast cancer |
Q35810123 | Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature |
Q36921698 | Recklessness as a hallmark of aggressive cancer |
Q42257030 | Reversion-inducing cysteine-rich protein with Kazal motifs gene expression and its clinical significance in peripheral T-cell lymphoma |
Q34770322 | TIMP-2 upregulates RECK expression via dephosphorylation of paxillin tyrosine residues 31 and 118. |
Q28504785 | The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis |
Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
Q24337918 | The tumor suppressor RECK interferes with HER-2/Neu dimerization and attenuates its oncogenic signaling |
Q78732223 | Transcriptional control of the RECK metastasis/angiogenesis suppressor gene |
Q48552283 | Valproic acid affected the survival and invasiveness of human glioma cells through diverse mechanisms. |
Search more.